
    
The genomic variant c.428G>A p.Arg143His, also known as rs121918719, is located on the TGM1 gene, which encodes for the enzyme transglutaminase 1 (TGase-1). TGase-1 plays a crucial role in the formation of the cornified cell envelope, a structure essential for the barrier function of the epidermis [4]. Mutations in TGM1, such as rs121918719, are associated with autosomal recessive congenital ichthyosis (ARCI), a heterogeneous group of rare cornification disorders characterized by dry, scaly skin [4].The rs121918719 variant results in the amino acid substitution of arginine to histidine at position 143 of the TGase-1 protein. This missense mutation has been identified in patients clinically diagnosed with hereditary ichthyosis and has been classified as pathogenic/likely pathogenic according to the American College of Medical Genetics and Genomics (ACMG) classification criteria [2]. The pathogenicity of this variant is further supported by segregation analysis within affected families [2].In a study that utilized whole exome sequencing (WES) for the molecular diagnosis of hereditary ichthyosis, the c.428G>A variant was identified alongside other mutations in TGM1 and ALOX12B genes. The identification of these mutations enabled carrier detection in at-risk relatives and offered opportunities for reproductive planning and prenatal diagnosis [2]. Another study reported the successful development of a skin-humanized mouse model for TG1-deficient lamellar ichthyosis using bioengineered human skin grafts from patients with TGM1 mutations, including c.428G>A. This model recapitulated the human skin phenotype and provided a platform for long-term pre-clinical studies and investigation of molecular mechanisms underlying the disease [3].The rs121918719 variant is the most commonly reported TGM1 mutation, particularly among North American and Norwegian patients, suggesting a possible founder effect. The high frequency of mutations at arginine codons in TGM1, including the Arg143 residue affected by rs121918719, may be attributed to the deamination of methylated CpG dinucleotides, which are hotspots for mutations [4].In summary, the c.428G>A p.Arg143His rs121918719 variant in the TGM1 gene is a pathogenic mutation that contributes to the clinical manifestations of ARCI. The TGM1 gene's function in epidermal barrier formation underscores the significance of this variant in the pathophysiology of hereditary ichthyosis. ClinVar has recorded a total of three pathogenic submissions for this variant, further corroborating its clinical relevance in the context of rare dermatological conditions.

TGM1遺伝子に位置するゲノム変異c.428G>A p.Arg143His（rs121918719としても知られる）は、酵素トランスグルタミナーゼ1（TGase-1）をコードしています。TGase-1は、表皮のバリア機能に不可欠な構造である角化細胞包膜の形成に重要な役割を果たします[4]。TGM1の変異、例えばrs121918719は、乾燥した鱗状の皮膚を特徴とする稀な角化障害の異質なグループである常染色体劣性先天性魚鱗癬（ARCI）と関連しています[4]。rs121918719変異は、TGase-1タンパク質の143番目の位置でアルギニンがヒスチジンに置換されるアミノ酸変化を引き起こします。このミスセンス変異は、遺伝性魚鱗癬と臨床的に診断された患者で確認されており、米国医療遺伝学およびゲノム学会（ACMG）の分類基準に基づいて病原性/病原性の可能性が高いと分類されています[2]。この変異の病原性は、影響を受けた家族内での分離分析によってさらに支持されています[2]。

遺伝性魚鱗癬の分子診断のために全エクソームシーケンシング（WES）を利用した研究では、c.428G>A変異がTGM1およびALOX12B遺伝子の他の変異とともに確認されました。これらの変異の特定により、リスクのある親族における保因者検出が可能となり、生殖計画や出生前診断の機会が提供されました[2]。別の研究では、c.428G>Aを含むTGM1変異を持つ患者からのバイオエンジニアリングされたヒト皮膚移植片を使用して、TG1欠損性層状魚鱗癬の皮膚ヒト化マウスモデルの開発に成功したと報告されています。このモデルはヒト皮膚の表現型を再現し、疾患の分子メカニズムを調査するための長期的な前臨床研究のプラットフォームを提供しました[3]。

rs121918719変異は、特に北米およびノルウェーの患者の間で最も一般的に報告されているTGM1変異であり、創始者効果の可能性を示唆しています。TGM1のアルギニンコドン、特にrs121918719によって影響を受けるArg143残基での変異の高頻度は、変異のホットスポットであるメチル化CpG二ヌクレオチドの脱アミノ化に起因する可能性があります[4]。

まとめると、TGM1遺伝子のc.428G>A p.Arg143His rs121918719変異は、ARCIの臨床症状に寄与する病原性変異です。表皮バリア形成におけるTGM1遺伝子の機能は、遺伝性魚鱗癬の病態生理学におけるこの変異の重要性を強調しています。ClinVarは、この変異に関して合計3件の病原性提出を記録しており、稀な皮膚疾患の文脈での臨床的関連性をさらに裏付けています。
    
## References
- [1] John SE et al. (2018). "Assessment of coding region variants in Kuwaiti population: implications for medical genetics and population genomics." Scientific reports, 8(1) [PubMed](https://pubmed.ncbi.nlm.nih.gov/30409984/)
- [2] Chegini M et al. (2023). "Whole exome sequencing identifies novel pathogenic variants in TGM1 and ALOX12B in patients with hereditary ichthyosis." Archives of dermatological research, 316(1) [PubMed](https://pubmed.ncbi.nlm.nih.gov/38060040/)
- [3] Aufenvenne K et al. (2012). "Long-term faithful recapitulation of transglutaminase 1-deficient lamellar ichthyosis in a skin-humanized mouse model, and insights from proteomic studies." The Journal of investigative dermatology, 132(7) [PubMed](https://pubmed.ncbi.nlm.nih.gov/22437313/)
- [4] Herman ML et al. (2009). "Transglutaminase-1 gene mutations in autosomal recessive congenital ichthyosis: summary of mutations (including 23 novel) and modeling of TGase-1." Human mutation, 30(4) [PubMed](https://pubmed.ncbi.nlm.nih.gov/19241467/)
- [5] Giannakis M et al. (2016). "Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma." Cell reports, 15(4) [SUPP] [PubMed](https://pubmed.ncbi.nlm.nih.gov/27149842/)
- [6] Ferrarini A et al. (2015). "The Use of Non-Variant Sites to Improve the Clinical Assessment of Whole-Genome Sequence Data." PloS one, 10(7) [SUPP] [PubMed](https://pubmed.ncbi.nlm.nih.gov/26147798/)
- [7] Holehouse AS et al. (2015). "Reproducible Analysis of Post-Translational Modifications in Proteomes--Application to Human Mutations." PloS one, 10(12) [SUPP] [PubMed](https://pubmed.ncbi.nlm.nih.gov/26659599/)

    
## ClinVar Submissions
- **[RCV000013299](https://www.ncbi.nlm.nih.gov/clinvar/RCV000013299/)**: Autosomal recessive congenital ichthyosis 1
- **[RCV001387567](https://www.ncbi.nlm.nih.gov/clinvar/RCV001387567/)**: not provided
- **[RCV001836706](https://www.ncbi.nlm.nih.gov/clinvar/RCV001836706/)**: Abnormality of the skin

    